Ibiglustat
CAS No. 1401090-53-6
Ibiglustat ( Venglustat;Genz-682452;GZ452 )
产品货号. M11673 CAS No. 1401090-53-6
An orally active, selective and potent Glucosylceramide synthase (GCS) inhibitor with central nervous system (CNS) access.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥648 | 有现货 |
|
5MG | ¥1320 | 有现货 |
|
10MG | ¥2390 | 有现货 |
|
25MG | ¥4220 | 有现货 |
|
50MG | ¥6116 | 有现货 |
|
100MG | ¥8586 | 有现货 |
|
500MG | ¥17172 | 有现货 |
|
1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Ibiglustat
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述An orally active, selective and potent Glucosylceramide synthase (GCS) inhibitor with central nervous system (CNS) access.
-
产品描述An orally active, selective and potent Glucosylceramide synthase (GCS) inhibitor with central nervous system (CNS) access; exhibits significantly lower tissue levels of GL-3 and lyso-GL-3 and a delayed progression of a thermal nociceptive response in administered Fabry mice; shows favorable pharmacological properties and safety profile.Other Indication Phase 2 Clinical
-
同义词Venglustat;Genz-682452;GZ452
-
通路Others
-
靶点Other Targets
-
受体glucosylceramide synthase
-
研究领域Other Indications
-
适应症Other Disease
化学信息
-
CAS Number1401090-53-6
-
分子量389.49
-
分子式C20H24FN3O2S
-
纯度>98% (HPLC)
-
溶解度DMSO: 10 mM ( < 1 mg/ml refers to the product slightly soluble or insoluble )
-
SMILESO=C(O[C@@H]1CN2CCC1CC2)NC(C)(C3=CSC(C4=CC=C(F)C=C4)=N3)C
-
化学全称(3S)-1-azabicyclo[2.2.2]octan-3-yl N-{2-[2-(4-fluorophenyl)- 1,3-thiazol-4-yl]propan-2-yl}carbamate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Ashe KM, et al. Mol Med. 2015 Apr 30;21:389-99.
2. Marshall J, et al. Mol Ther. 2016 Jun;24(6):1019-1029.
2. Marshall J, et al. Mol Ther. 2016 Jun;24(6):1019-1029.
产品手册
关联产品
-
Rhamnetin
Rhamnetin, a quercetin derivative found in Coriandrum sativum, has antioxidant and anti-inflammatory activities. Rhamnetin inhibits secretory phospholipase A2.
-
3-Galloylquercitrin
1. 3''-Galloylquercitrin possesses the activity for PTK inhibition.
-
Lyoniside
Lyoniside and saracoside are cytotoxic to promastigotes and intracellular amastigotes, they demonstrate strong anti-leishmanial efficacies in BALB/c mice model of leishmaniasis, suggests that these two compounds potential anti-leishmanial candidates.